Sakboonyarat, Boonsub
Poovieng, Jaturon
Lertsakulbunlue, Sethapong
Jongcherdchootrakul, Kanlaya
Srisawat, Phutsapong
Mungthin, Mathirut
Rangsin, Ram
Funding for this research was provided by:
The Research Unit for Military Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand.
Article History
Received: 4 December 2022
Accepted: 11 March 2023
First Online: 21 March 2023
Declarations
:
: This study was reviewed and approved by the Institutional Review Board, Royal Thai Army Medical Department, according to international guidelines such as the Declaration of Helsinki, the Belmont Report, CIOMS Guidelines, and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use–Good Clinical Practice (ICH–GCP) (approval number S067h/64 & S056h/65). As a result of using secondary data, a waiver of documentation of informed consent was utilized. The Institutional Review Board, Royal Thai Army Medical Department, approved an informed consent waiver.
: Consent for publication is not applicable.
: The authors declare no competing interests.